Diasorin S.p.a. · MIL:DIA
Diasorin — Investor Day
13 slides from Diasorin's investor day presentation
Slide 1: R&D and Innovation
R&D AND INNOVATION Francesco Colotta Senior Corporate VP and Chief Medical Officer
Slide 2: In Vitro Diagnostics: Basics
IN VITRO DIAGNOSTICS: BASICS DETECTION IN BIOLOGICAL FLUIDS... E.G. BLOOD, URINE, CSF,… IN VITRO DIAGNOSTICS E.G. PROTEINS NUCLEIC ACIDS SMALL MOLECULES IMMUNODIAGNOSTICS MOLECULAR DIAGNOSTICS CLINICAL CHEMISTRY ...OF A “MOLECULE”... DETECTION BY ANTIBODIES… DETECTION BY DNA… DETECTION BY CHEMICAL R
Slide 3: Areas to Be a Front Runner in Lab Testing
AREAS TO BE A FRONT RUNNER IN LAB TESTING • STRENGTHEN OUR LEADERSHIP IN IMMUNOASSAY • BECOME A NEW PLAYER IN MOLECULAR DIAGNOSTIC IMMUNODIAGNOSTICS MOLECULAR DIAGNOSTICS DETECTION BY ANTIBODIES… DETECTION BY DNA… …BY A LIGHT-EMITTING MOLECULE …BY A FLUORESCENCE-EMITTING MOLECULE BLOOD BANKS INFECTI
Slide 4: Blood Banks Development Program
BLOOD BANKS DEVELOPMENT PROGRAM LEVERAGE DIASORIN EXPERIENCE AND REPUTATION IN IDS LEVERAGE DIASORIN FULL MENU AVAILABILITY T. pallidum BLOOD HBsAg HTLV I-II BANKS HCV Chagas HIV HIV HT LIAISON XL In development DIASORIN LEVERAGING EXPERIENCE, REPUTATION, FULL MENU AVAILABILITY, LIAISON XL
Slide 5: New Automated System in Stool Testing
NEW AUTOMATED SYSTEM IN STOOL TESTING SET UP OF OPTIMAL ASSAY CONDITIONS COMPANION ONE-STEP SIMPLE SAMPLE WITH LIAISON AND LIAISON XL PREPARATION DEVICE GI INFECTIONS C. DIFFICILE TOXINS A&B ENTEROHEMORRAGIC E. COLI C. DIFFICILE GDH ROTAVIRUS H. PYLORI ADENOVIRUS GI INFLAMMATORY/AUTOIMMUNE DISEASES
Slide 6: Leverage on Bone Metabolism Franchise
LEVERAGE ON BONE METABOLISM FRANCHISE CHRONIC KIDNEY DISEASE (CKD) AND BONE METABOLISM CKD BONE MASS LOSS HIGH BONE TURNOVER LOW BONE TURNOVER (INCREASED REABSORPTION) (REDUCED FORMATION) HYPERPHOSPHATEMIA FGF-23 HYPERPHOSPHATEMIA FGF-23 REDUCED 1,25 VITD 1,25 VITD SPECIFIC ASSAY REDUCED 1,25 VITD 1
Slide 7: Hypertension: A Full Panel on LIAISON Systems
HYPERTENSION: A FULL PANEL ON LIAISON SYSTEMS DIASORIN MENU: A UNIQUE OFFER FOR THE DETECTION OF THE KEY HYPERTENSION MARKERS ON A FULLY AUTOMATED PLATFORM DIFFERENT “TYPES” OF HYPERTENSION RENOVASCULAR HYPERTENSION RENIN-SECRETING TUMORS HIGH RENIN ESSENTIAL HYPERTENSION LOW RENIN ESSENTIAL HYPERTE
Slide 8: DiaSorin in the Molecular Diagnostics: The 3 Key Decisions
DIASORIN IN THE MOLECULAR DIAGNOSTICS DIASORIN STRATEGY TO PLAY THE MOLECULAR DIAGNOSTIC MARKET THE 3 KEY DECISIONS AUTOMATED NA AMPLIFICATION AMPLIFICATION TECHNOLOGY NAT MENU AND DETECTION INSTRUMENT INFECTIOUS DISEASES LAMP LIAISON IAM AND ONCOHEMATOLOGY TESTS 3 DECISIONS, 1 WINNING STRATEGY IN M
Slide 9: LAMP to Develop a Specialty Menu in NAT
LAMP TO DEVELOP A SPECIALTY MENU IN NAT DIASORIN LICENSED LAMP (LOOP-MEDIATED ISOTHERMAL AMPLIFICATION) TECHNOLOGY FROM EIKEN CHEMICAL COMPANY LTD IN 2008: THE DIFFERENTIATION FACTOR IN ONCO-HEMATOLOGY FUTURE MENU DIASORIN LAMP grants: HIGHER SENSITIVITY HIGHER SPECIFICITY SIMPLER REACTION SET-UP SH
Slide 10: LIAISON IAM: A Small Automated Analyzer
LIAISON IAM: A SMALL AUTOMATED ANALYZER DIASORIN SIGNED AN AGREEMENT WITH PRECISION SYSTEM SCIENCE CO. LTD OF JAPAN (PSS) FOR THE DEVELOPMENT OF A NUCLEIC ACID TEST (NAT) ANALYZER Liaison Instant Amplification Molecular (IAM) CLIENTS S DIASORIN MICROBIOLOGY CUSTOMERS DIASORIN SPECIALITIES SEROLOGY CU
Slide 11: NAT Menu: Focus on Specialties
NAT MENU: FOCUS ON SPECIALTIES LEVERAGE DIASORIN EXPERIENCE AND PROVIDE THE SPECIALIST REPUTATION IN INFECTIOUS DISEASES WITH A COMPLETE PANEL INFECTIOUS DISEASES SPECIALTIES ONCO-HEMATOLOGY SPECIALTIES EPSTEIN–BARR VIRUS (EBV) MYELOPROLIFERATIVE NEOPLASMS (MYELO NEOPL) CYTOMEGALOVIRUS (CMV) ACUTE L
Slide 12: LAS Configuration and LIAISON XL
LAS CONFIGURATION AND LIAISON XL LAS BRINGS LIAISON XL INTO THE MOST ADVANCED, HIGH THROUGHPUT AND AUTOMATED DIAGNOSTIC LABS, TO FULFILL FLEXIBILITY AND EFFICIENCY OF THE NEW ANALYZER DEVELOPMENT PLAN: • UPGRADE SW AND HW TO INTEGRATE LIAISON XL INTO AUTOMATED PATIENT SAMPLE PROCESSING: LABORATORY A
Slide 13: DiaSorin: R&D Pipeline 2011 - 2015
DIASORIN: R&D PIPELINE 2011 - 2015 LEVERAGE DIASORIN EXPERIENCE BLOOD BANK K AND REPUTATION IN IDS HTLV I-II CHAGAS HIV - HT INFECTIOUS DISEASES AUTOMATED STOOL TESTING DEVELOP AN INNOVATIVE IMMUNODIAGNOSTIC CHEMILUMINESCENT PLATFORM CHARACTERIZED BY: C. DIFFICILE H. PYLORI ENTER E. COLI · BIOLOGICA